li Zhang
Sun Yat-Sen University Cancer Center · Sun Yat-sen University · The Second Affiliated Hospital of Air Force Military Medical University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name li Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:46 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT07702955 · Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid TumorsKangabio AUSTRALIA LTD PTY · not yet recruiting · Advanced or Metastatic Solid Tumors · principal investigator
- Ph2/Ph3NCT07636226 · QL1706 Plus Anlotinib as a Later-line Treatment for Patients With Advanced Lung CancerSun Yat-sen University · not yet recruiting · Small Cell Lung Cancer · principal investigator
- N/ANCT07610668 · Clinical Value of Saline Infusion Sonohysterography in the Assessment of Cesarean Scar DefectsTang-Du Hospital · recruiting · Infertility · principal investigator
- N/ANCT07494877 · Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in InfertilityTang-Du Hospital · recruiting · Infertility · principal investigator
- Ph2NCT07489703 · SHR-A1811 + AK112 in HER2-Altered Advanced/Metastatic NSCLCSun Yat-sen University · not yet recruiting · Non-Small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT07222969 · A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid TumorsVibrant Sciences Limited · recruiting · Advanced Solid Tumors · principal investigator
- Ph1NCT07205198 · A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.Shanghai Institute Of Biological Products · recruiting · Advanced Tumors · principal investigator
- Ph1/Ph2NCT07198321 · A Single-Arm, Open-Label, Multicenter Phase I/II Clinical Study of GFH276 in Patients With RAS-Mutant Advanced Solid TumorsGenfleet Therapeutics (Shanghai) Inc. · not yet recruiting · Cancer, PDAC, CRC (Colorectal Cancer) · principal investigator
- Ph1/Ph2NCT07157956 · CVL006 Combination Therapy in Advanced Solid TumorsConvalife (Shanghai) Co., Ltd. · not yet recruiting · Advanced Solid Tumor · principal investigator
- Ph1NCT07130617 · Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly Emetogenic ChemotherapyChangchun GeneScience Pharmaceutical Co., Ltd. · not yet recruiting · Efficacy, Safety, Megestrol Acetate · principal investigator
- Ph3NCT07010419 · A Study to Assess the Efficacy and Safety of Firmonertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB - IIIB NSCLC With Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations, Following Complete Surgical Resection With or Without Adjuvant Chemotherapy(FIRMOST)Allist Pharmaceuticals, Inc. · recruiting · NSCLC, Adjuvant Treatment · principal investigator
- Ph1NCT06898255 · A Phase I Study to Evaluate GFS202A in Advanced Solid Tumor Patients With Pre-cachexia or CachexiaGenfleet Therapeutics (Shanghai) Inc. · recruiting · Cancer Cachexia · principal investigator
- Ph1NCT06883630 · A Phase Ib Study of RC148 as Monotherapy or Combination for Locally Advanced or Metastatic NSCLCRemeGen Co., Ltd. · active not recruiting · Non-Small Cell Lung Cancer · study director
- Ph1NCT06882135 · HW071021 Monotherapy in Patients With Advanced Solid TumorsWuhan Humanwell Innovative Drug Research and Development Center Limited Company · recruiting · Advanced Solid Tumors · principal investigator
- Ph1NCT06868732 · Evaluation of JSKN016 Combination Therapy in Subjects With NSCLCJiangsu Alphamab Biopharmaceuticals Co., Ltd · recruiting · Advanced Non-small Cell Lung Cancer · principal investigator
- Ph2NCT06783647 · A Clinical Trial of LBL-024 Combination Drug in Patients With Advanced Solid Tumours[Substudy 01(NSCLC)]Nanjing Leads Biolabs Co.,Ltd · recruiting · Advanced Solid Tumour · principal investigator
- Ph2NCT06775483 · Evaluation of JSKN016 in the Treatment of Advanced Non-small Cell Lung Cance: a Phase II Clinical StudyJiangsu Alphamab Biopharmaceuticals Co., Ltd · not yet recruiting · Advanced Non-small Cell Lung Cancer · principal investigator
- N/ANCT06764290 · Neural Changes in Stroke Patients During Challenging Walking Tasks.Nanjing Medical University · recruiting · Stroke · study director
- Ph3NCT06735391 · A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive MutationsShanghai JMT-Bio Inc. · recruiting · Locally Advanced or Metastatic Non-squamous NSCLC, Harboring EGFR Sensitive Mutations NSCLC, Previously Untreated Systematically NSCLC · principal investigator
- N/ANCT06686134 · Comprehensive Clinical Evaluation Study of GLP-1RALI YAN · recruiting · T2DM · principal investigator
- Ph2NCT06514027 · Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion MutationsBeBetter Med Inc · recruiting · Non Small Cell Lung Cancer · principal investigator
- Ph3NCT06500026 · A Study Comparing BL-B01D1 With Topotecan in Patients With Recurrent Small Cell Lung Cancer(PANKU-Lung03)Sichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Small Cell Lung Cancer · principal investigator
- Ph1NCT06475131 · A Study of BL-B16D1 in Patients With Locally Advanced or Metastatic Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Solid Tumor · principal investigator
- Ph2NCT06475300 · A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma, Solid Tumor · principal investigator
- N/ANCT06395142 · Plantar Pressure and Electroencephalographic Signals During Pedal and Vision-deprived Walking in Stroke Patients.Geriatric Hospital of Nanjing Medical University · completed · Stroke · study chair
- Ph2NCT06391944 · JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common MutationsShanghai JMT-Bio Inc. · active not recruiting · Local Advanced or Metastatic NSCLC, Harboring EGFR Common Mutation · principal investigator
- Ph3NCT06382116 · A Study Comparing BL-B01D1 With Platinum Based Chemotherapy in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer(PANKU-Lung01)Sichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph3NCT06380348 · JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins MutationsShanghai JMT-Bio Inc. · not yet recruiting · Local Advanced or Metastatic NSCLC · principal investigator
- Ph2/Ph3NCT06319313 · Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung CancerShanghai JMT-Bio Inc. · not yet recruiting · Squamous Cell Non-small Cell Lung Cancer · principal investigator
- N/ANCT06234618 · The Effect of Covered Eye Walking on Electroencephalogram in Stroke Patients Compared With Open Eye WalkingNanjing Medical University · suspended · Stroke · study director
- N/ANCT06215885 · Multi-omics Analysis to Characterize the Invasive Evolution of Pulmonary Subsolid NodulesCancer Institute and Hospital, Chinese Academy of Medical Sciences · unknown · Adenocarcinoma of Lung · principal investigator
- Ph1NCT06169579 · An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid CancersShenzhen NewDEL Biotech, Co., Ltd · enrolling by invitation · Advanced Solid Tumor · principal investigator
- Ph1NCT06128148 · Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid TumorsGuangzhou JOYO Pharma Co., Ltd · recruiting · Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Neoplasms · principal investigator
- Ph3NCT06118333 · A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)Sichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Nasopharyngeal Carcinoma · principal investigator
- Ph1/Ph2NCT06114511 · A Study of BL-M07D1 in Patients With HER2-Overexpressing or HER2-Mutant Locally Advanced or Metastatic Non-Small Cell Lung CancerSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph3NCT06082635 · TGRX-326 Chinese Phase III for Advanced Non-small Cell Lung Cancer (NSCLC)Shenzhen TargetRx Co., Ltd. · active not recruiting · Non Small Cell Lung Cancer · principal investigator
- Ph1NCT06032936 · BBP-398 in Combination With Osimertinib in Locally Advanced or Metastatic NSCLC Patients With EGFR MutationsLianBio LLC · terminated · NSCLC · principal investigator
- Ph1/Ph2NCT06022757 · Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19)Evopoint Biosciences Inc. · terminated · Carcinoma, Squamous Cell Carcinoma of Head and Neck, Urothelial Carcinoma · principal investigator
- N/ANCT05958576 · Effect of Age on Sperm Recovery of Microdissection Testicular Sperm Extraction in Nonobstructive Azoospermia PatientsPeking University Third Hospital · completed · Non-obstructive Azoospermia · principal investigator
- Ph2NCT05956587 · A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma · principal investigator
- Ph2NCT05955391 · TGRX-326 Chinese Phase II for Advanced Non-small Cell Lung Cancer (NSCLC)Shenzhen TargetRx Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- N/ANCT05890287 · A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line ChemotherapyTianjin Medical University Cancer Institute and Hospital · unknown · HR Positive HER2 Negative Advanced Breast Cancer · principal investigator
- Ph1/Ph2NCT05869240 · BPB-101 in Subjects With Metastatic or Locally Advanced Solid TumorsBetta Pharmaceuticals Co., Ltd. · unknown · Solid Tumor · study chair
- Ph1/Ph2NCT05824455 · A Clinical Study of IMP4297 Capsule (JS109) Combined With Irinotecan in the Treatment of Advanced Malignant Solid TumorsShanghai Jun Pai Ying Shi Therapeutics Co., Ltd. · terminated · Advanced Solid Tumors · principal investigator
- Ph1NCT05767060 · BAT7104 Injection in Patients With Advanced Malignant Tumors.Bio-Thera Solutions · completed · Advanced Malignant Tumor · principal investigator
- N/ANCT05719337 · Multi-Modality Echocardiographic Techniques in Pathological Left Ventricular Hypertrophy AdultsFirst Hospital of China Medical University · unknown · Left Ventricular Hypertrophy · principal investigator
- Ph3NCT05690945 · A Study of QL1706 in Combination With Chemotherapy in PD-L1-Negative Non-small Cell Lung CancerQilu Pharmaceutical Co., Ltd. · active not recruiting · Lung Cancer · principal investigator
- Ph3NCT05683600 · Efficacy and Safety of COVID-19 Vaccine as Booster Vaccination in Adults 18 Years of Age or OlderGuangzhou Patronus Biotech Co., Ltd. · terminated · COVID-19 · principal investigator
- Ph2/Ph3NCT05623267 · Sugemalimab as Consolidation Therapy in Patients With LS-SCLC Following cCRT or sCRTSun Yat-sen University · recruiting · Limited Stage Small Cell Lung Cancer · principal investigator
- Ph1NCT05621525 · Phase I Study of the BBP-398 in Patients With Advance Solid TumorsLianBio LLC · terminated · Advanced Solid Tumor, Advanced or Metastatic Non-small Cell Lung Cancer · principal investigator
- N/ANCT05583409 · SBRT Combined With Osimertinib Compared With Osimertinib for Stage IV NSCLCLi Zhang · unknown · Stage IV Non-small Cell Lung Cancer · principal investigator
- Ph2/Ph3NCT05576272 · A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal CarcinomaQilu Pharmaceutical Co., Ltd. · unknown · Nasopharyngeal Carcinoma · principal investigator
- Ph1/Ph2NCT05516914 · A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant TumorsNanjing Leads Biolabs Co.,Ltd · completed · Malignant Tumors · principal investigator
- Ph1/Ph2NCT05505877 · Phase I/IIa Study of BR790 in Combination With Tislelizumab in Adult Subjects With Advanced Solid TumorsShanghai Gopherwood Biotech Co., Ltd. · unknown · Advanced Solid Tumor · principal investigator
- N/ANCT05487066 · Efficacy of ICU-VTE Scale in ICU PatientsLijuan Zhang · completed · Venous Thromboembolism · principal investigator
- N/ANCT05450757 · Shanghai ST-segment Elevation Myocardial Infarction CohortRuijin Hospital · unknown · ST Elevation Myocardial Infarction · study chair
- Ph1NCT05441956 · TGRX-326 Chinese Phase I for Advanced Non-small Cell Lung Cancer (NSCLC)Shenzhen TargetRx Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- N/ANCT05433922 · Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the ElderlyInstitute of Hematology & Blood Diseases Hospital, China · unknown · Severe Aplastic Anemia · study director
- Ph1NCT05429398 · A Study of Linperlisib Combination With Camrelizumab in Patients With Solid TumorShanghai YingLi Pharmaceutical Co. Ltd. · unknown · Advanced Solid Tumor · principal investigator
- Ph2NCT05420220 · Study of KN046 in Subjects With Advanced Non-Small Cell Lung CancerJiangsu Alphamab Biopharmaceuticals Co., Ltd · completed · Advanced Non-small Cell Lung Cancer · principal investigator
- Ph1NCT05405621 · Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009Bio-Thera Solutions · unknown · Locally Advanced/Metastatic Solid Tumours · principal investigator
- Ph4NCT05329038 · Immunogenicity,Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 VaccineSinovac Life Sciences Co., Ltd. · unknown · COVID-19 · principal investigator
- Ph1NCT05262842 · JS001+IMP4297 in Patients With Advanced CancerShanghai Junshi Bioscience Co., Ltd. · withdrawn · Advanced Cancer · principal investigator
- N/ANCT05214885 · Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell CarcinomaQianfoshan Hospital · recruiting · Clear Cell Renal Cell Carcinoma · principal investigator
- Ph2NCT05195632 · Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung CancerPierre Fabre Medicament · active not recruiting · Non-Small Cell Lung Cancer · principal investigator
- Ph1NCT05194982 · A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Solid TumorSichuan Baili Pharmaceutical Co., Ltd. · recruiting · Locally Advanced or Metastatic Solid Tumor · principal investigator
- Ph3NCT05184712 · Phase 3 Clinical Study of AK112 for NSCLC PatientsAkeso · active not recruiting · Non-Squamous Non-small Cell Lung Cancer · principal investigator
- Ph4NCT05182463 · Peginterferon Treatment Study for Inactive Chronic Hepatitis B PatientsThird Affiliated Hospital, Sun Yat-Sen University · recruiting · Hepatitis B, Chronic · principal investigator
- Ph1/Ph2NCT05173805 · Phase I Clinical Study of YL-15293 in Patients With Advanced Solid Tumor With KRAS MutationShanghai YingLi Pharmaceutical Co. Ltd. · unknown · Advanced Solid Tumor · principal investigator
- Ph1NCT05171790 · A Study to Evaluate the Efficacy and Safety of QL1706 Injection in Patients With Solid TumorsQilu Pharmaceutical Co., Ltd. · unknown · Advanced Solid Tumors · principal investigator
- Ph2NCT05162872 · Niraparib And Sintilimab In Recurrent/Metastatic Nasopharyngeal CarcinomaSun Yat-sen University · unknown · Nasopharyngeal Carcinoma · principal investigator
- Ph4NCT05138705 · Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 YearsShanghai Institute Of Biological Products · completed · Influenza, Human · principal investigator
- Ph2NCT05132777 · Efficacy and Safety of JMT101 Combined With Osimertinib in Patients With Non-Small Cell Lung CancerShanghai JMT-Bio Inc. · unknown · Locally Advanced or Metastatic Non-Small Cell Lung Cancer, EGFR Exon20 Insertion Mutations · principal investigator
- Ph1NCT05105971 · Assessment of Safety and Preliminary Efficacy With BAT6026 in Solid Tumor Patients in ChinaBio-Thera Solutions · completed · Advanced Solid Tumors · principal investigator
- Ph1/Ph2NCT05102006 · A Phase Ib/II Clinical Study of LBL-007 in Combination With Toripalimab in Treatment of Advanced Malignant TumorsNanjing Leads Biolabs Co.,Ltd · completed · Advanced Malignant Tumors · principal investigator
- Ph2NCT05068427 · Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.Chipscreen Biosciences, Ltd. · completed · Non Small Cell Lung Cancer · principal investigator
- Ph1NCT05028556 · A Trial of Y101D, a PD-L1/TGF-β Bispecific Antibody, in Patients With Metastatic or Locally Advanced Solid TumorsWuhan YZY Biopharma Co., Ltd. · completed · Metastatic or Locally Advanced Solid Tumors · principal investigator
- Ph2NCT05020457 · SI-B001 Combined With Chemotherapy in the Treatment of EGFR/ALK WT Recurrent or Metastatic NSCLC.Sichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non Small Cell Lung Cancer · principal investigator
- Ph2/Ph3NCT05020769 · SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.Sichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Non-small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT05016544 · Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung CancerSun Yat-sen University · unknown · Non-small Cell Lung Cancer · principal investigator
- Ph1NCT05003622 · Phase 1 Safety Study of Encorafenib in Chinese Patients With Advanced Metastatic BRAF V600E Mutant Solid TumorsPierre Fabre Medicament · completed · BRAF V600E Unresectable or Metastatic Melanoma, BRAF V600E Metastatic NSCLC, Melanoma · principal investigator
- Ph2NCT04992858 · Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping MutationsSunshine Lake Pharma Co., Ltd. · withdrawn · Advanced NSCLC · principal investigator
- N/ANCT04980339 · Multimodal Imaging Evaluation and Prognostic Analysis of Participants After Arterial Switch OperationXie Mingxing · not yet recruiting · Arterial Switch Operation · principal investigator
- N/ANCT04976517 · Echocardiographic Assessment of the Impact of Diabetes and Prognostic Analysis of Heart TransplantationXie Mingxing · unknown · Heart Transplant · principal investigator
- N/ANCT04974372 · A Multicenter Clinical Study of Ultrasound Multimodal Imaging in the Evaluation of Heart TransplantationXie Mingxing · unknown · Heart Transplant · principal investigator
- N/ANCT04966988 · Multimodal Imaging Evaluation and Prognostic Analysis of Cardiac Allograft Vasculopathy in Heart TransplantationXie Mingxing · unknown · Heart Transplant · principal investigator
- Ph4NCT04953325 · Immunogenicity and Safety of an Inactivated COVID-19 VaccineSinovac Research and Development Co., Ltd. · completed · COVID-19 · principal investigator
- Ph2NCT04736823 · A Trial of AK112 (PD1/VEGF Bispecific) in Combination With Chemotherapy in Patients With NSCLCAkeso · active not recruiting · NSCLC · study chair
- N/ANCT04663438 · Real World Study of Efficacy and Safety of Atezolizumab Plus Chemotherapy in Chinese Patients With ES-SCLCPeking Union Medical College Hospital · unknown · Extensive-stage Small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT04647344 · A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung CancerAkeso · completed · Lung Cancer Non-Small Cell Stage IIIB/IIIC/IV · principal investigator
- Ph1NCT04603287 · A Study of SI-B001, an EGFR/HER3 Bispecific Antibody, in Locally Advanced or Metastatic Epithelial TumorsSichuan Baili Pharmaceutical Co., Ltd. · active not recruiting · Locally Advanced or Metastatic Epithelial Tumor · principal investigator
- Ph1NCT04577703 · First-In-Human Phase I Trial of Ningetinib ( CT053PTSA ) in the Patients With Advanced Solid TumorsSunshine Lake Pharma Co., Ltd. · completed · Advanced Solid Tumors · principal investigator
- Ph1NCT04397926 · Phase I Study of Individualized Neoantigen Peptides in the Treatment of EGFR Mutant Non-small Cell Lung CancerSun Yat-sen University · unknown · Non Small Cell Lung Cancer · principal investigator
- Ph1NCT04390984 · Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC PatientsJiangsu HengRui Medicine Co., Ltd. · unknown · NSCLC · principal investigator
- Ph1NCT04296994 · A Study of QL1706 in Subjects With Advanced Malignant TumorQilu Pharmaceutical Co., Ltd. · unknown · Advanced Malignant Tumor · principal investigator
- Ph2NCT04177875 · Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal CancerTongji Hospital · unknown · Esophagus Cancer · principal investigator
- Ph1/Ph2NCT04172454 · Safety and Efficacy of AK104, a PD-1/CTLA-4 Bispecific Antibody, in Selected Advanced Solid TumorsAkeso · completed · Advanced Solid Tumors, Melanoma · principal investigator
- Ph2NCT04164745 · Efficacy and Safety Study of Anlotinib With Pembrolizumab in Adults With Programmed Cell Death-Ligand 1 (PD-L1)-Positive Treatment-naïve Non-small Cell Lung CancerPeking Union Medical College Hospital · unknown · NSCLC · principal investigator
- Ph2NCT04085250 · Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation TherapySun Yat-sen University · unknown · Stage III Non-small-cell Lung Cancer · principal investigator
- Ph3NCT04009317 · Study of TQ-B3139 Versus Crizotinib in the First Line Treatment of Subjects With Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC)Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · unknown · ALK-positive NSCLC · principal investigator
- Ph1NCT04001777 · A Study of APG-1252 Plus Osimertinib(AZD9291) in EGFR TKI Resistant NSCLC PatientsAscentage Pharma Group Inc. · active not recruiting · EGFR Positive Non-small Cell Lung Cancer · principal investigator
- Ph1NCT03917043 · APG-2449 in Patients With Advanced Solid TumorsAscentage Pharma Group Inc. · recruiting · Advanced Solid Cancer, Non Small Cell Lung Cancer, Esophageal Cancer · principal investigator
- Ph1/Ph2NCT03758287 · Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M NegativeSunshine Lake Pharma Co., Ltd. · completed · Non-small Cell Lung Cancer · principal investigator
- Ph3NCT03707509 · Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal CarcinomaJiangsu HengRui Medicine Co., Ltd. · unknown · Nasopharyngeal Carcinoma · principal investigator
- Ph3NCT03607539 · Efficacy and Safety Evaluation of Sintilimab in Patients With Advanced or Metastatic Non-squamous NSCLCInnovent Biologics (Suzhou) Co. Ltd. · completed · Lung Neoplasms · principal investigator
- Ph2NCT03595644 · Maintenance Targeted Therapy With or Without Stereotactic Body Radiation Therapy for Stage IV Non-small Cell Lung CancerTongji Hospital · completed · Stage IV Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03558191 · SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Chemotherapy.Jiangsu HengRui Medicine Co., Ltd. · completed · Nasopharyngeal Carcinoma · principal investigator
- Ph1NCT03527251 · Anti-CTLA-4 Antibody Followed by Anti-PD-1 Antibody in Recurrent or Metastatic NSCLCSun Yat-sen University · unknown · Non Small Cell Lung Cancer · principal investigator
- Ph2NCT03486587 · A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated DiarrheaSun Yat-sen University · terminated · Diarrhea, Treatment Side Effects · principal investigator
- Ph1NCT03330834 · CAR-T Cell Immunotherapy for Advanced Lung CancerSun Yat-sen University · terminated · Advanced Lung Cancer · principal investigator
- Ph3NCT03262948 · Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung CancerCSPC ZhongQi Pharmaceutical Technology Co., Ltd. · unknown · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT03215693 · X-396 Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With CrizotinibBetta Pharmaceuticals Co., Ltd. · unknown · Non-Small Cell Lung Cancer · study chair
- Ph4NCT03081845 · A1 Versus A2® Milk on the Gastrointestinal Physiology, Symptoms and Cognitive Behaviour for the Preschool Childrena2 Milk Company Ltd. · completed · Gut Inflammation · study director
- N/ANCT03049579 · Immune System Stimulation by Probiotic Food SupplementationHangzhou Wei Chuan Foods Co., Ltd. · completed · Flu Symptom · study director
- N/ANCT03037086 · Asia PDL1 Study Among NSCLC PatientsAstraZeneca · completed · Locally Advanced or Metastatic NSCLC · principal investigator
- Ph1NCT02959619 · Ensartinib in Non-small Cell Lung Cancer Patients With Positive ALKBetta Pharmaceuticals Co., Ltd. · completed · Solid Tumor, Non-Small Cell Lung Cancer Metastatic · study chair
- Ph3NCT02954172 · Evaluate the Efficacy and Safety of IBI305 in Patients With Advanced or Recurrent Non-squamous NSCLCInnovent Biologics (Suzhou) Co. Ltd. · completed · NSCLC · principal investigator
- Ph2NCT02737709 · Paclitaxel Detection in NSCLC Treated With TC RegimenSun Yat-sen University · terminated · Non-small Cell Lung Cancer · principal investigator
- N/ANCT02738593 · Detection Cell Free DNA in Lung Cancer PatientsSun Yat-sen University · unknown · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT02650544 · Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With DepressionSun Yat-sen University · unknown · Carcinoma, Non-Small-Cell Lung, Depression · principal investigator
- Ph2NCT02646020 · Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus TreatmentSun Yat-sen University · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT02356991 · A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)Jiangsu HengRui Medicine Co., Ltd. · suspended · Non-Small Cell Lung Cancer (NSCLC) · principal investigator
- Ph1/Ph2NCT02274337 · Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of AC0010 in Advanced Non Small Cell Lung CancerSun Yat-sen University · unknown · Non-Small Cell Lung Cancer · principal investigator
- Ph2NCT02250599 · Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal CarcinomaSun Yat-sen University · unknown · Nasopharyngeal Neoplasms · principal investigator
- Ph4NCT02202083 · The Comparison of Oxytocin Induced Labor and Cook Balloon Induced LaborWest China Second University Hospital · unknown · Labor; Forced or Induced, Affecting Fetus or Newborn · study director
- N/ANCT02155426 · Prognostic and Dynamic Change of CTC Enumeration in Advanced NSCLC With Chemotherapy and Targeted TherapySun Yat-sen University · unknown · Non Small Cell Lung Cancer · principal investigator
- Ph2NCT02006043 · Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-)Li Zhang · unknown · Non-small Cell Lung Cancer · principal investigator
- Ph2/Ph3NCT01914107 · Real-time Cancer Pain Assessment and InterventionSun Yat-sen University · unknown · Malignancy, Pain · principal investigator
- N/ANCT01914120 · the Quality of Life Assessment of Lung Cancer Patients in ChinaSun Yat-sen University · unknown · Lung Cancer · principal investigator
- N/ANCT01891123 · Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing StrategySun Yat-sen University · unknown · Non-small Cell Lung Cancer, Breast Cancer, Nasal Cancer · principal investigator
- Ph3NCT01882621 · Monosialoganglioside(GM1) Preventing Neurotoxicity Induced by Cisplatin Contained Chemotherapy in NSCLC PatientsSun Yat-sen University · unknown · Non-small Cell Lung Cancer · principal investigator
- Ph1/Ph2NCT01735409 · Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal CarcinomaSun Yat-sen University · unknown · Nasopharyngeal Neoplasms · principal investigator
- Ph2NCT01533727 · CIK Cell Transfusion Plus Chemotherapy as Adjuvant Therapy for Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC)Sun Yat-sen University · withdrawn · Non-small Cell Lung Cancer · principal investigator
- Ph1NCT01531790 · A Study of Continuous Endostar Intravenous Infusion Combined With Pemetrexed and Carboplatin in Advanced Non Small Cell Lung Cancer PatientsJiangsu Simcere Pharmaceutical Co., Ltd. · completed · Non-Small Cell Lung Cancer · principal investigator
- Ph3NCT01528618 · Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal CarcinomaSun Yat-sen University · completed · Nasopharyngeal Neoplasms · principal investigator
- Ph2/Ph3NCT01528488 · Prophylactic EVOZAC® Calming Skin Spray for EGFR-TKIs Associated Rash Eruption in NSCLCSun Yat-sen University · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT01347424 · Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement UltrasonographySun Yat-sen University · unknown · Non Small Cell Lung Cancer, Nasopharyngeal Cancer, Liver Metastasis · principal investigator
- Ph3NCT01287962 · Apatinib in the Treatment of Advanced Non-squamous Non-small Cell Lung CancerSun Yat-sen University · unknown · Non-small Cell Lung Cancer · study chair
- Ph2NCT01270386 · A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung CancerJiangsu HengRui Medicine Co., Ltd. · completed · Non-Small-Cell Lung Cancer · principal investigator
- Ph1NCT01260025 · Tolerability and Pharmacokinetics of M2ES in the Treatment of Advanced Solid TumorSun Yat-sen University · completed · Tolerability, Pharmacokinetics, Endostatin · principal investigator
- Ph1NCT01226030 · Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid TumorsBeijing Protgen Biotechnology Development Co., Ltd. · unknown · Advanced Solid Tumors · principal investigator
- Ph2NCT01194453 · Pemetrexed Plus Cisplatin Versus Gemcitabine Plus Cisplatin for Advanced NSCLC Metastatic Non-small Cell Lung CancerSun Yat-sen University · completed · Non-small Cell Lung Cancer, Efficacy · study chair
- Ph3NCT01040780 · Safety and Efficacy Study of Icotinb in Non-small Cell Lung Cancer (NSCLC) PatientsBetta Pharmaceuticals Co., Ltd. · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT01017679 · Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mgSun Yat-sen University · completed · Non-small Cell Lung Cancer · principal investigator
- Ph2NCT00816868 · A Phase II Study of TX Regimen as First-line Treatment for Asian Elderly Patients With Advanced Adenocarcinoma of LungSun Yat-sen University · completed · Non-small Cell Lung Cancer · study chair
- Ph4NCT00762346 · Efficacy and Safety Study of ZOMETA® in Treatment of High-level NTX Non Small Cell Lung Cancer With Bone MetastasisSun Yat-sen University · completed · Non Small Cell Lung Cancer, Bone Metastases, High NTX Level · principal investigator
- Ph2NCT00747799 · Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)Sun Yat-sen University · completed · Nasopharyngeal Neoplasms · principal investigator
- Ph2NCT00697619 · To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal CancerSun Yat-sen University · completed · Nasopharyngeal Cancer · principal investigator
- Ph2NCT00630149 · Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based ChemotherapySun Yat-sen University · completed · Nasopharyngeal Neoplasms · principal investigator
- Ph3NCT00615667 · Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)Sun Yat-sen University · completed · Kidney Diseases, Nephrotic Syndrome, Tacrolimus · principal investigator
- Ph3NCT00615173 · Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus NephritisSun Yat-sen University · completed · Kidney Diseases, Lupus Nephritis, Tacrolimus · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 146 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Alveolar Macrophage Iron Overload in COPD PathogenesisK08HL165081 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · fiscal years 2023 to 2026 · $169,020 awarded in 2026Same name and institution; not confirmed by an ID
- Deciphering the mitochondrial proton leakR35GM151226 · NIGMS · TEMPLE UNIV OF THE COMMONWEALTH · fiscal years 2023 to 2026 · $396,250 awarded in 2026Same name and institution; not confirmed by an ID
- Vending machines: a low-barrier method to deliver public health services in the communityK23DA060412 · NIDA · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · fiscal years 2025 to 2026 · $200,772 awarded in 2026Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:46 UTC. The ranking covers the 200 most relevant of 3416 PubMed records, and a shared surname and initials can bring in a namesake. All 3416 on PubMed
- 87 citationsRCR 31.2
- Disitamab Vedotin plus Toripalimab in HER2-Expressing Advanced Urothelial Cancer.N Engl J Med · 202582 citationsRCR 16.4
- 72 citationsRCR 13.1
- Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC.N Engl J Med · 202672 citationsRCR 35.9
- 63 citationsRCR 13.8
- 55 citationsRCR 16.0
- 53 citationsRCR 15.7
- Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial.Nat Med · 202550 citationsRCR 16.8
- 45 citationsRCR 22.6
- 43 citationsRCR 7.7